CHPA Statement on President Obama’s Nomination for FDA Commissioner

Washington, D.C. (September 16, 2015) — The Consumer Healthcare Products Association (CHPA) issued the following statement today supporting President Obama’s nomination for the next commissioner of the Food and Drug Administration (FDA). The White House announced yesterday that the president will nominate Robert Califf, M.D. – a prominent cardiologist and researcher who was previously named FDA’s deputy commissioner for medical products and tobacco.

“Having served in a senior leadership role at FDA after a distinguished career in medicine and academia, Dr. Califf is an excellent choice to lead the Food and Drug Administration,” CHPA President and CEO Scott Melville said. “Once confirmed, Dr. Califf will take the helm at a pivotal time for the FDA and our nation’s healthcare policies. More than ever, Americans want to take greater personal control over their own health and are ready to embrace more self-care options. OTC medicines provide accessible and affordable healthcare solutions, and our industry looks forward to working with the new commissioner so that the OTC industry can continue to grow and meet the needs of consumers in our evolving healthcare environment.”


 
The Consumer Healthcare Products Association (CHPA) is the 134-year-old trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $6-$7, contributing a total of $102 billion in savings each year. CHPA is committed to promoting the increasingly vital role of over-the-counter medicines and dietary supplements in America’s healthcare system through science, education, and advocacy.

 

chpa.org